Structure of UNC2025
CAS No.: 1429881-91-3
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
UNC2025 is an inhibitor of Mer and Flt3 with IC50 of 0.8 nM and 0.74 nM, respectively.
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1429881-91-3 |
Formula : | C28H40N6O |
M.W : | 476.66 |
SMILES Code : | O[C@H]1CC[C@H](N2C=C(C3=CC=C(CN4CCN(C)CC4)C=C3)C5=CN=C(NCCCC)N=C52)CC1 |
MDL No. : | MFCD28142874 |
InChI Key : | MJSHVHLADKXCML-UHFFFAOYSA-N |
Pubchem ID : | 73425588 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
TRP | 231.6 nM | 5 days | Evaluate the inhibitory effect of UNC2025 on TRP cell growth, with an IC50 of 231.6 nM. | PMC5761530 |
EWS894 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
MHH-ES-1 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
Kasumi-1 AML cells | 200-300nM | 48 hours | Induced cell death, 25-90% of cells died after 48-hour treatment | PMC5354980 |
CHLA-32 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
GSC20 | 1.5 µM | 5 days | Evaluate the inhibitory effect of UNC2025 on GSC20 cell growth, with an IC50 of 1.5 µM. | PMC5761530 |
GSC11 | 86 nM | 5 days | Evaluate the inhibitory effect of UNC2025 on GSC11 cell growth, with an IC50 of 86 nM. | PMC5761530 |
SK-N-MC cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
CHLA-10 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
TC-71 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
A673 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
AML-123009 patient sample | 25-300nM | 48 hours | Inhibited colony formation, >90% inhibition at 300nM | PMC5354980 |
Jurkat T-ALL cells | 200-300nM | 48 hours | Induced cell death, 25-90% of cells died after 48-hour treatment | PMC5354980 |
697 B-ALL cells | 200-300nM | 48 hours | Induced cell death, 25-90% of cells died after 48-hour treatment | PMC5354980 |
M2 macrophages | 1 µg/mL | 2 hours | Inhibit MerTK phosphorylation and block efferocytosis of apoptotic cells | PMC10039929 |
EOC 2 | 199 nM | 5 days | Evaluate the inhibitory effect of UNC2025 on EOC 2 cell growth, with an IC50 of 199 nM. | PMC5761530 |
J774 | 134 nM | 5 days | Evaluate the inhibitory effect of UNC2025 on J774 cell growth, with an IC50 of 134 nM. | PMC5761530 |
TC-32 cells | 1 μM | 24 hours | UNC2025 suppressed SN-38-induced Akt and ERK signaling activation | PMC11192891 |
NOMO-1 AML cells | 200-300nM | 48 hours | Induced cell death, 25-90% of cells died after 48-hour treatment | PMC5354980 |
697 B-ALL cells | 0.01, 0.1, 1.0, 10, 100, 1000 nM | 10 minutes | Induced cell death, 25-90% of cells died after 48-hour treatment | PMC4148167 |
Bone marrow-derived dendritic cells (BMDCs) | 10 µg/mL | 12 hours | To evaluate the effect of Loratadine on dendritic cell antigen-presenting function, results showed that Loratadine significantly reduced the production of IL-4, IL-13, and IL-17A | PMC10039929 |
B16F10 melanoma cells | 5 µM | 6 hours | Cell apoptosis was assessed by FITC-Annexin V and TUNEL staining. Clofazimine induced apoptosis. | PMC10039929 |
Schwannoma cells | 0.03-6.0 μM | 72 hours and 7 days | UNC2025 decreased the total number of schwannoma cells, increased the number of dead cells, and reduced the proliferation of Ki67-positive cells. | PMC11458476 |
Meningioma cells | 0.03-6.0 μM | 72 hours and 7 days | UNC2025 decreased the total number of meningioma cells, increased the number of dead cells, and reduced the proliferation of Ki67-positive cells. | PMC11458476 |
Murine washed platelets | 0.5 µM | 15 minutes | Inhibited collagen-stimulated platelet aggregation | PMC5858881 |
Human platelet rich plasma (PRP) | 5 µM | 15 minutes | Inhibited collagen-stimulated platelet aggregation | PMC5858881 |
Human washed platelets (WP) | 0.5 µM | 15 minutes | Inhibited collagen-stimulated platelet aggregation | PMC5858881 |
Meningioma cells | 1 µM | 72 hours | UNC2025 decreased the total number of meningioma cells, increased the number of dead cells, and reduced the proliferation of Ki67-positive cells. | PMC10725030 |
MeWo | 100 nM | 72 hours | Reduction in survivin levels | PMC9787186 |
A101D | 50 nM | 10 days | Reduction in colony formation | PMC9787186 |
G361 | 1000 nM | 90 minutes | Inhibition of MERTK activation and downstream signaling | PMC9787186 |
HMCB | 300 nM | 90 minutes | Inhibition of MERTK activation and downstream signaling | PMC9787186 |
H1299 | 300 nM | 72 hours | PMC4704683 | |
Colo699 | 300 nM | 72 hours | To assess the effect of UNC2025 on apoptosis, results showed UNC2025 significantly increased apoptosis. | PMC4704683 |
A549 | 300 nM | 72 hours | Evaluate cytotoxicity, showing low cytotoxicity | PMC4704683 |
H2228 | 300 nM | 72 hours | To assess the effect of UNC2025 on apoptosis, results showed UNC2025 significantly increased apoptosis. | PMC4704683 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Mice | TRP allograft model | Oral gavage | 65 mg/kg | Once daily starting from day 7 | Evaluate the effect of UNC2025 alone or in combination with radiotherapy on the survival of TRP allograft model mice. Results showed that UNC2025 alone did not significantly prolong survival, but when combined with radiotherapy, 19.4% of mice survived more than 60 days, with complete tumor regression in some mice. | PMC5761530 |
Nude mice | MHH-ES-1 xenograft model | Intraperitoneal injection | 10 mg/kg | Every 3 days for 28 days | UNC2025 enhanced irinotecan's suppression of tumor growth | PMC11192891 |
NSG mice | 697 B-ALL xenograft model | Oral | 50-75mg/kg | Once daily, continuous treatment | Significantly reduced tumor burden, median survival increased from 26 days to 70 days | PMC5354980 |
NOD/SCID/gamma mice | Human leukemia xenograft model | Oral | 3 mg/kg | Single dose, bone marrow cells collected 30 minutes later | To evaluate the inhibitory effect of UNC2025 on Mer phosphorylation in vivo, results showed significant reduction in Mer phospho-protein levels | PMC4148167 |
C57BL/6 mice | B16F10 melanoma model | Peritumoral injection | 2.7 µg UNC2025/mouse | Every 3 days for two times | Inhibit tumor growth and metastasis, enhance antitumor immune responses | PMC10039929 |
Mice | FeCl3-Induced Carotid Artery Thrombosis model | Intravenous injection | 3 mg/kg | Single dose, circulated for 30 minutes | Prolonged time to initial clot formation and decreased thrombus stability | PMC5858881 |
Male C57BL/6 mice | Hepatic ischemia-reperfusion injury model | Intravenous injection | 50 mg/kg | Single dose, followed by reperfusion for up to 6 or 24 hours | UNC2025 significantly inhibited MSC-EVs-induced phagocytosis of apoptotic cells by macrophages and increased liver injury | PMC11387478 |
Nude mice | BRAF-mutated patient-derived xenograft model | Oral gavage | 50 mg/kg | Twice daily for 50 days | Significantly reduced tumor growth | PMC9787186 |
Nude mice | Subcutaneous xenograft model | Oral gavage | 30 mg/kg or 50 mg/kg | Twice daily for several weeks | To assess the effect of UNC2025 on tumor growth, results showed UNC2025 significantly inhibited tumor growth. | PMC4704683 |
Tags: UNC2025 | UNC 2025 | UNC-2025 | FLT3 | Cluster of differentiation antigen 135 | CD135 | Fms like tyrosine kinase 3 | Mer inhibitor | Flt3 inhibitor | ATP-competitive | kinase inhibitor | 1429881-91-3
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL